Warfarin Pharmacology Episode 032

Warfarin serves as a critical vitamin K antagonist that prevents blood clots and strokes by inhibiting clotting factors II, VII, IX, and X through the VKORC complex. Clinical management requires precise monitoring of the International Normalized Ratio (INR), typically targeting a range of 2.0 to 3.0, alongside periodic Complete Blood Count (CBC) tests to detect potential anemia from internal bleeding. While vitamin K acts as a pharmacological antidote, its reversal effects are not instantaneous. Dosing remains highly individualized, influenced by age, genetics, and dietary vitamin K intake. Significant risks arise from extensive drug interactions; specifically, antibiotics like Bactrim and Flagyl can dangerously elevate INR levels, while inducers like Rifampin or St. John’s Wort may reduce efficacy. Furthermore, concurrent use of antiplatelet agents such as aspirin or NSAIDs significantly exacerbates the risk of gastrointestinal hemorrhage.